Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Revenue Disaggregation (Details Narrative)

Revenue Disaggregation (Details Narrative) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Rest Of World To Asia [Member]
Disaggregation of Revenue [Line Items]
Reclass of revenues	$ 188	$ 283

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details